The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of Pfizer COVID-19 in Nigeria.
The agency’s approval is coming a few months after it gave a nod for the use of the Oxford-Astrazeneca jabs.
NAFDAC through its Director-General, Mojisola Adeyeye announced this during a virtual meeting on Friday in Abuja, the nation’s capital, explaining that the vaccine is for emergency use.
Earlier in March, Nigeria had received 3.9 million doses of the Astranezeneca jabs and also flagged off the vaccination exercise during an event organized by the National Primary Health Care Development Agency (NPHCDA) in Abuja.
“I think that is about the best news we’ve heard since, said medical doctor, Ngong Cyprian, the first person to take the vaccine in Nigeria.
“I only wished my dad had had this vaccine, maybe months ago or so. We lost him but we thank God, and the fight is still on and we will win”, she assured.
Since the vaccination campaign began, over 600, 000 persons have taken the jabs, as the country records a lower number of infections.
